Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
UBS
Mallinckrodt
Deloitte
Boehringer Ingelheim
Chubb
Teva
Express Scripts
Moodys
Cipla

Generated: October 18, 2017

DrugPatentWatch Database Preview

METHERGINE Drug Profile

« Back to Dashboard

What is the patent landscape for Methergine, and when can generic versions of Methergine launch?

Methergine is a drug marketed by Edison Theraps Llc and is included in one NDA.

The generic ingredient in METHERGINE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.

Summary for Tradename: METHERGINE

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list7
Clinical Trials: see list3
Patent Applications: see list189
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHERGINE at DailyMed

Pharmacology for Tradename: METHERGINE

Ingredient-typeErgolines
Drug ClassErgot Derivative
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Edison Theraps Llc
METHERGINE
methylergonovine maleate
INJECTABLE;INJECTION006035-004Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Edison Theraps Llc
METHERGINE
methylergonovine maleate
TABLET;ORAL006035-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Fuji
Queensland Health
Daiichi Sankyo
Boehringer Ingelheim
Citi
Express Scripts
Merck
Teva
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot